tradingkey.logo

BUZZ-ReShape Lifesciences slumps after $6 mln public offering

ReutersFeb 18, 2025 1:19 PM

Shares of metabolic health solutions firm ReShape Lifesciences RSLS.O fall 57.5% to $1 premarket

On Saturday, RSLS said it is raising $6 mln through a public offering of shares and warrants

Co selling ~2.6 mln units, each consisting of one share and one warrant, at $2.33 per unit

Warrants can be exercised at a price of $5.83 per share, after stockholder approval

Maxim Group LLC is acting as the sole agent for the offering

RSLS fell ~71% in 2024

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI